The DOI matches its Crossref record; 30 of the 30 references it cites were found in a registry or an index.
Biological and clinical manifestations of juvenile Huntington’s disease: A retrospective analysis
Abstract
Background Huntington's disease is a rare, neurodegenerative disease caused by an expanded CAG repeat mutation in the huntingtin gene. Compared with adult-onset Huntington's disease, juvenile Huntington's disease (onset ≤20 years) is even rarer and has not been studied extensively. We aimed to further characterise juvenile Huntington's disease by examining the effect of CAG repeat size on disease presentation, progression, and survival.Methods We did a retrospective analysis of patients with juvenile Huntington's disease aged 20 years or younger, according to the length of their CAG repeat and who had disabling psychiatric symptoms (with motor symptoms) or motor symptoms alone, and of patients with adult-onset Huntington's disease manifesting aged 30-60 years with 40 or more CAG repeats, from the REGISTRY and ENROLL-HD platforms and from two institutional databases (Lega Italiana Ricerca Huntington Foundation and the Instituto Neurociencias de Buenos Aires and the Sanatorio de la Trinidad Mitre). Patients with psychiatric but no motor symptoms were excluded. We compared symptoms at onset and longitudinally in patients with juvenile Huntington's disease with highly expanded (HE subgroup) or low expansion (LE subgroup) mutations, grouped by hierarchical clustering analysis. We also compared disease progression (longitudinal change in Unified Huntington's Disease Rating Scale-Total Motor Score) and survival of patients with juvenile and adult-onset Huntington's disease.Findings We extracted medical records from 580 patients entered into the studies or databases between June 23, 2004, and March 31, 2018, of whom 36 patients met our definition of juvenile Huntington's disease and 197 for adult-onset Huntington's disease. According to caregiver reports, gait disturbance was more often a first presenting symptom in the HE subgroup (eight [80%] of 10 patients) than in the LE subgroup (seven [27%] of 26 patients; p=0·0071), whereas loss of hand dexterity was more common in the LE subgroup (11 [42%] of 26 patients) than in the HE subgroup (0 [0%] of 10 patients; p=0·0160). Compared with the LE subgroup, development delay (0 [0%] in the LE subgroup vs nine [90%] in the HE subgroup; p<0·0001), severe gait impairment (nine [35%] in the LE subgroup vs nine [90%] in the HE subgroup; p=0·0072), and seizures (three [11%] in the LE subgroup vs eight [80%] in the HE subgroup; p<0·0001) prevailed over time in the HE subgroup. Disease progression was more rapid in juvenile Huntington's disease (n=14) than in adult-onset Huntington's disease (n=52; generalised estimating equation model, p=0·0003). Of 121 deceased patients, median survival was shorter in the juvenile Huntington's disease (n=17) cohort than in adult-onset Huntington's disease (n=104) cohort (hazard ratio 2·18 [95% CI 1·08-4·40]; p=0·002).Interpretation Patients with HE juvenile Huntington's disease differ clinically from patients with LE juvenile Huntington's disease or adult-onset Huntington's disease, suggesting reclassification of this particularly aggressive form of Huntington's disease might be required.Funding Lega Italiana Ricerca Huntington Foundation and IRCCS Ospedale Casa Sollievo della Sofferenza.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“One of the most pertinent genetic phenomena in HD is called anticipation, which is when the number of repeats exceeds 55, increasing in each generation [249]. This process can result in Juvenile HD, an aggressive form of the disease that has a significantly earlier onset [250].”
From The Impact of Neurotoxin Proteins Trafficked by Primary Cilia and Extracellular Vesicles in Neurodegenerative Diseases (2025) · cites this paper as [250]
Citations
Cites
MACDONALD, M. (1993) · Cell · doi:10.1016/0092-8674(93)90585-e · Cited by 8,366
(1975) · CERN Document Server (European Organization for Nuclear Research) · Cited by 5,958
Shah, M. A., Datson, N. A., Srinidhi, L., Stanton, V. P., MacDonald, M. E., Allard, M. W., Youngman, S., Am, F., Mott, R., Draths, K., et al. (1993) · Cell · Cited by 3,055
Unified Huntington's disease rating scale: Reliability and consistency
(1996) · Movement Disorders · doi:10.1002/mds.870110204 · Cited by 2,079
Sibson, R., & Hartigan, J. A. (1976) · Applied Statistics · doi:10.2307/2346526 · Cited by 1,435
Unified Huntington's disease rating scale: reliability and consistency
Kremer, H. P. H. (1996) · Radboud Repository (Radboud University) · Cited by 1,059
Tabrizi, S. J., Langbehn, D. R., Leavitt, B. R., Roos, R. A., Durr, A., Craufurd, D., Kennard, C., Hicks, S. L., Fox, N. C., Scahill, R. I., et al. (2009) · The Lancet Neurology · doi:10.1016/s1474-4422(09)70170-x · Cited by 984
Tabrizi, S. J., Scahill, R. I., Owen, G., Durr, A., Leavitt, B. R., Roos, R. A., Borowsky, B., Landwehrmeyer, B., Frost, C., Johnson, H., et al. (2013) · The Lancet Neurology · doi:10.1016/s1474-4422(13)70088-7 · Cited by 846
Self-citationCAG repeat number governs the development rate of pathology in Huntington's disease
Penney, J. B., Vonsattel, J., Macdonald, M. E., Gusella, J. F., & Myers, R. H. (1997) · Annals of Neurology · doi:10.1002/ana.410410521 · Cited by 669
Self-citationIdentification of Genetic Factors that Modify Clinical Onset of Huntington’s Disease
Lee, J.-M., Wheeler, V. C., Chao, M. J., Vonsattel, J. P. G., Pinto, R. M., Lucente, D., Abu-Elneel, K., Ramos, E. M., Mysore, J. S., Gillis, T., et al. (2015) · Cell · doi:10.1016/j.cell.2015.07.003 · Cited by 655
Self-citation
Research works printed but not linked: 1
- Hensman Moss, 2017, Identification of genetic variants associated with Huntington's disease progression: a genome-wide association study, Lancet Neurol, 16, 701, 10.1016/S1474-4422(17)30161-8 · DOI · Paper page
Cited by
Ciosi, M., Maxwell, A., Cumming, S. A., Hensman Moss, D. J., Alshammari, A. M., Flower, M. D., Durr, A., Leavitt, B. R., Roos, R. A. C., Holmans, P., et al. (2019) · EBioMedicine · doi:10.1016/j.ebiom.2019.09.020 · Cited by 174
Therapeutic Advances for Huntington’s Disease
Kumar, A., Kumar, V., Singh, K., Kumar, S., Kim, Y.-S., Lee, Y.-M., & Kim, J.-J. (2020) · Brain Sciences · doi:10.3390/brainsci10010043 · Cited by 164
Pinto, R. M., Arning, L., Giordano, J. V., Razghandi, P., Andrew, M. A., Gillis, T., Correia, K., Mysore, J. S., Urtubey, D.-M. G., Parwez, C. R., et al. (2020) · Human Molecular Genetics · doi:10.1093/hmg/ddaa139 · Cited by 137
Self-citationTiming and Impact of Psychiatric, Cognitive, and Motor Abnormalities in Huntington Disease
McAllister, B., Gusella, J. F., Landwehrmeyer, G. B., Lee, J., MacDonald, M. E., Orth, M., Rosser, A., Williams, N. M., Holmans, P., Jones, L., et al. (2021) · Neurology · doi:10.1212/wnl.0000000000011893 · Cited by 150
Self-citationJuvenile parkinsonism: Differential diagnosis, genetics, and treatment
Niemann, N., & Jankovic, J. J. (2019) · Parkinsonism & Related Disorders · doi:10.1016/j.parkreldis.2019.06.025 · Cited by 135
Metadata
- Authors
- Fusilli, C., Migliore, S., Mazza, T., Consoli, F., De Luca, A., Barbagallo, G., Ciammola, A., Gatto, E. M., Cesarini, M., Etcheverry, J. L., Parisi, V., Al-Oraimi, M., Al-Harrasi, S., Al-Salmi, Q., Marano, M., Vonsattel, J.-P. G., Sabatini, U., Landwehrmeyer, G. B., & Squitieri, F.
- Affiliations
- Casa Sollievo della Sofferenza (IT)
- Magna Graecia University (IT)
- IRCCS Istituto Auxologico Italiano (IT)
- Instituto de Neurología de Buenos Aires (AR)
- Ministry of Health (OM)
- Columbia University (US)
- University Hospital Ulm (DE)
- Corresponding author
- Squitieri, Ferdinando
- ORCID
- Venue
- The Lancet Neurology
- Publisher
- Elsevier BV
- Published
- 2018-11
- Volume
- 17
- Issue
- 11
- Pages
- 986-993
- ISSN
- 1474-4422 (ISSN-L)
- OpenAlex
- W2889749509
- Cited by
- 148
- References
- 30
- Citations by year
- 2026: 12 · 2025: 17 · 2024: 18 · 2023: 20 · 2022: 22 · 2021: 17 · 2020: 23 · 2019: 14 · 2018: 3
- FWCI
- 6.97
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.elsevier.com/tdm/userlicense/1.0/ (tdm)
- www.elsevier.com/legal/tdmrep-license (tdm)
- Locations
- The Lancet Neurology (publishedVersion)
- PubMed (publishedVersion)
- Archivio Istituzionale della Ricerca - Università degli Studi dell Aquila (submittedVersion)
- Topics
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Genetic Neurodegenerative Diseases
- Health Sciences › Medicine › Clinical Neurology › Deep Brain Stimulation and Movement Disorders
- Social Sciences › Psychology › Clinical Psychology › Obsessive-Compulsive Spectrum Disorders
- Keywords
- juvenile Huntington's disease, CAG repeat expansion, huntingtin gene, disease presentation, motor symptoms, psychiatric symptoms, gait disturbance, manual dexterity, developmental delay, disease progression, survival, Unified Huntington's Disease Rating Scale, Enroll-HD, neurodegeneration, genotype-phenotype correlation, first presenting symptom
- MeSH terms
- Huntingtin Protein, Adolescent, Adult, Child, Female, Humans, Huntington Disease, Longitudinal Studies, Magnetic Resonance Imaging, Male, Medical Records, Registries, Retrospective Studies, Disease Progression, Trinucleotide Repeats, Young Adult
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Biological and clinical manifestations of juvenile Huntington’s disease: A retrospective analysis. https://app.cochat.ai/papers/10.1016/s1474-4422(18)30294-1
- The paper
- Fusilli, C., Migliore, S., Mazza, T., Consoli, F., De Luca, A., Barbagallo, G., Ciammola, A., Gatto, E. M., Cesarini, M., Etcheverry, J. L., Parisi, V., Al-Oraimi, M., Al-Harrasi, S., Al-Salmi, Q., Marano, M., Vonsattel, J.-P. G., Sabatini, U., Landwehrmeyer, G. B., & Squitieri, F. (2018). Biological and clinical manifestations of juvenile Huntington’s disease: A retrospective analysis. The Lancet Neurology. https://doi.org/10.1016/s1474-4422(18)30294-1
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.